NCT02940496 2025-07-15
Pembrolizumab (MK-3475) in Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
15 trialsNCT04710641 2025-03-06
OUTREACH2
Mina Alpha Limited
Phase 2 Completed
NCT02143401 2024-11-22
Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT04540081 2023-12-27
CLOVER
University of California, Davis
Phase NA Completed
NCT03903185 2023-08-22
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
Ain Shams University
Phase 1/2 Completed
NCT04653818 2023-04-04
RCT
Alexandria University
Phase 4 Completed
NCT02970136 2021-12-28
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
University of Miami
Phase NA Completed
NCT02868242 2020-03-02
Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy
Gilead Sciences
Phase 2 Completed
NCT02833298 2018-10-12
Post Sustained Virological Response (SVR) Hepatocellular Carcinoma (HCC) Screening
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT00513461 2018-08-10
Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
University of California, Irvine
Phase 2 Completed
NCT01804829 2017-03-15
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients.
Biotest Pharmaceuticals Corporation
Phase 3 Completed
NCT01790633 2016-12-13
OPTISCREEN-III
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase NA Completed
NCT01559844 2016-07-27
Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant
Gilead Sciences
Phase 2 Completed
NCT01022476 2013-07-18
LIVERAL
ANRS, Emerging Infectious Diseases
Phase 1/2 Completed
NCT00273247 2006-01-09
Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis
National Cancer Institute, Milan
Phase 3 Completed